IL80376A0 - Process and plasmid for production of insulin-like growth factor 1 - Google Patents

Process and plasmid for production of insulin-like growth factor 1

Info

Publication number
IL80376A0
IL80376A0 IL80376A IL8037686A IL80376A0 IL 80376 A0 IL80376 A0 IL 80376A0 IL 80376 A IL80376 A IL 80376A IL 8037686 A IL8037686 A IL 8037686A IL 80376 A0 IL80376 A0 IL 80376A0
Authority
IL
Israel
Prior art keywords
fused
plasmid
igf
insulin
production
Prior art date
Application number
IL80376A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858525929A external-priority patent/GB8525929D0/en
Priority claimed from GB868617073A external-priority patent/GB8617073D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL80376A0 publication Critical patent/IL80376A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL80376A 1985-10-21 1986-10-21 Process and plasmid for production of insulin-like growth factor 1 IL80376A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858525929A GB8525929D0 (en) 1985-10-21 1985-10-21 Production of insulin-like growth factor
GB868617073A GB8617073D0 (en) 1986-07-14 1986-07-14 Insulin-like growth factor i

Publications (1)

Publication Number Publication Date
IL80376A0 true IL80376A0 (en) 1987-01-30

Family

ID=26289914

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80376A IL80376A0 (en) 1985-10-21 1986-10-21 Process and plasmid for production of insulin-like growth factor 1

Country Status (10)

Country Link
EP (1) EP0219814B1 (de)
JP (1) JPH07114702B2 (de)
KR (1) KR880001813A (de)
AT (1) ATE67243T1 (de)
CA (1) CA1297814C (de)
DE (1) DE3681398D1 (de)
DK (1) DK502786A (de)
ES (1) ES2029785T3 (de)
GR (1) GR3002696T3 (de)
IL (1) IL80376A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789550T2 (de) * 1986-12-31 1994-08-25 Lucky Ltd Verfahren zur herstellung eines rinderwachstumshormons mittels eines kunstgens.
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
JP2574549B2 (ja) * 1991-03-08 1997-01-22 萩原 義秀 新規プラスミド
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207842A (en) * 1983-04-25 1988-02-12 Chiron Corp Production of human insulin-like growth factor (igf) using cdna
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
HU194307B (en) * 1983-09-16 1988-01-28 Richter Gedeon Vegyeszet Process for producing plasmidvectors of high copy number
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i

Also Published As

Publication number Publication date
ES2029785T3 (es) 1992-10-01
ATE67243T1 (de) 1991-09-15
EP0219814A1 (de) 1987-04-29
EP0219814B1 (de) 1991-09-11
KR880001813A (ko) 1988-04-27
JPS62175192A (ja) 1987-07-31
GR3002696T3 (en) 1993-01-25
DK502786D0 (da) 1986-10-20
JPH07114702B2 (ja) 1995-12-13
DE3681398D1 (de) 1991-10-17
DK502786A (da) 1987-04-22
CA1297814C (en) 1992-03-24

Similar Documents

Publication Publication Date Title
EP0214435A3 (en) Alkaline protease, method for the production of hybrid vectors and genetically transformed microorganisms
IL107814A0 (en) Cloning and eypression of biologically active alphagalactosidase a
DE3379591D1 (en) Microbially prepared interferon alpha2(arg), dna sequence coding for said interferon, microorganisms containing this genetic information and process for their production
EP0769551A4 (de) Für die erhöhung der carotenoidensbeute nützliches dna-strang
AU588793B2 (en) Method of expressing alpha-1-antitrypsin in bacteria
IL80376A0 (en) Process and plasmid for production of insulin-like growth factor 1
HU896613D0 (en) Process for the preparation of tgf-betal/beta2 chimer
DE3071292D1 (en) Recombinant bacteriophage for heterologous cloning of bacillus microorganisms and method for its production
AU6698090A (en) Bacterial collagenase gene
EP0280407A3 (de) Verfahren zur Herstellung rekombinanter Polypeptide mit Schweine-Wachstumshormonaktivität
EP0264074A3 (en) Expression vector for insulin-like growth factor i
AU604475B2 (en) The gal operon streptomyces
EP0254315A3 (en) Method for producing peptides
EP0064681A3 (de) Rekombinante DNS
AU2857192A (en) Gene coding for esterase and novel microorganism containing said gene
GR960300069T1 (en) Novel cholesterol oxidase
HU9203485D0 (en) Method for producing new plasmides
EP0323838A3 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten